Analysts have varying opinions on the stock, with 12 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The average price recommended by analysts for Ventyx Biosciences Inc. (VTYX) is $57.58, which is $24.13 above the current market price. The public float for VTYX is 54.22M and currently, short sellers hold a 14.28% of that float. On May 26, 2023, VTYX’s average trading volume was 856.43K shares.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
VTYX) stock’s latest price update
The stock price of Ventyx Biosciences Inc. (NASDAQ: VTYX) has dropped by -6.88 compared to previous close of 35.92. Despite this, the company has seen a fall of -0.33% in its stock price over the last five trading days.
VTYX’s Market Performance
Ventyx Biosciences Inc. (VTYX) has experienced a -0.33% fall in stock performance for the past week, with a -8.73% drop in the past month, and a -21.66% drop in the past quarter. The volatility ratio for the week is 5.15%, and the volatility levels for the past 30 days are at 5.39% for VTYX. The simple moving average for the past 20 days is -9.48% for VTYX’s stock, with a 1.23% simple moving average for the past 200 days.
VTYX Trading at -5.49% from the 50-Day Moving Average
After a stumble in the market that brought VTYX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -29.21% of loss for the given period.
Volatility was left at 5.39%, however, over the last 30 days, the volatility rate increased by 5.15%, as shares sank -8.48% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -10.56% lower at present.
During the last 5 trading sessions, VTYX fell by -0.33%, which changed the moving average for the period of 200-days by +97.00% in comparison to the 20-day moving average, which settled at $36.80. In addition, Ventyx Biosciences Inc. saw 2.01% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at VTYX starting from Sandborn William J., who sale 3,487 shares at the price of $36.47 back on May 15. After this action, Sandborn William J. now owns 34,662 shares of Ventyx Biosciences Inc., valued at $127,182 using the latest closing price.
Mohan Raju, the Chief Executive Officer of Ventyx Biosciences Inc., sale 30,000 shares at $39.28 during a trade that took place back on May 05, which means that Mohan Raju is holding 1,543,126 shares at $1,178,502 based on the most recent closing price.
Stock Fundamentals for VTYX
Equity return is now at value -36.90, with -34.50 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 20.21.
Conclusion
To wrap up, the performance of Ventyx Biosciences Inc. (VTYX) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
